SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Natco Pharma

Natco Pharma

BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01018 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Dec 10, 16:30
1378.70
45.35 (+3.40%)
VOLUME 2,395
AVERAGE VOLUME
5-Day 7,540
10-Day 5,076
30-Day 5,238
VOLUME SHOCKER
5-Day 7,540
10-Day 5,076
30-Day 5,238
Prev. Close
1333.35
Open Price
1395.70
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 1352.00 1395.70
52 Wk Low/High 655.55 1585.70
LIVE
NSE
Dec 10, 16:30
1379.70
54.35 (+4.10%)
VOLUME 16,443
AVERAGE VOLUME
5-Day 42,398
10-Day 28,737
30-Day 39,703
VOLUME SHOCKER
5-Day 42,398
10-Day 28,737
30-Day 39,703
Prev. Close
1325.35
Open Price
1335.25
Bid PRICE (QTY.)
1379.70 (94)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 1335.25 1384.95
52 Wk Low/High 650.00 1590.00
Action in Natco Pharma

No recommendations so far.

What's your call on Natco Pharma today?
Read 5 investor views

MARKET CAP (Rs Cr)
4,650.04
*P/E
35.61
*BOOK VALUE (Rs)
218.49
DIV (%)
50.00%
Market Lot
1
INDUSTRY P/E
23.55
*EPS (TTM)
38.72
*P/C
29.52
*PRICE/BOOK
6.31
DIV YIELD.(%)
0.36%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
73.53 new
DELIVERY AVERAGES
3-Day 63.15%
5-Day 51.38%
8-Day 53.63%
* Based on standalone numbers
Track Natco Pharma on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

18 December 2014

buy

BHEL Dec Fut

Entry Price (Rs)

254.00

Exit Price (Rs)

257.50

Gain (Rs)

4.00

buy

ITC Dec Fut

Entry Price (Rs)

372.00

Exit Price (Rs)

377.50

Gain (Rs)

6.00

buy

CanaraBank Dec Fut

Entry Price (Rs)

428.00

Exit Price (Rs)

432.50

Gain (Rs)

5.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 799.20 1395.70  
High Price 813.50 1395.70  
Low Price 790.00 1352.00  
Last Price 805.55 1378.70 71.15
Volume 21,666 2,395 -88.95
Simple Moving Averages
Days BSE NSE
30 1400.85 1400.49
50 1402.10 1401.59
150 1182.89 1183.19
200 1086.03 1086.39

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Natco Pharma

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Consolidated (Sep '14)
(Jun '14)
Net Sales 209.06 190.48
Other Income 3.19 1.52
PBDIT 62.04 58.69
Net Profit 31.24 32.21

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
(Jun '14)
(In Rs Cr)
Total Share Capital 33.07
Net Worth 732.90
Total Debt 193.60
Net Block 528.98
Investments 88.90
Net Current Assets 215.70
Total Assets 926.52
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 812.75 0.12 932.00 552.50 168,333.85
Lupin 1425.25 2.28 1500.00 882.80 64,023.92
Dr Reddys Labs 3150.50 -0.31 3662.00 2250.00 53,673.76
Cipla 625.10 3.28 671.95 366.70 50,190.61
Cadila Health 1536.95 2.91 1760.00 794.00 31,468.82
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 14Jun' 14Mar' 14Dec' 13
Promoter53.5253.5253.5453.70
FII16.6314.5313.0011.46
DII7.848.779.7210.83
Others22.0123.1823.7424.01
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Natco House, Road No.2,,Banjara Hills
City
Hyderabad
State
Telangana
Pin Code
500033
Tel. No.
040-23547532
Fax No.
040-23548243
REGISTRARS
Name
Venture Capital & Corporate Investments Pvt. Ltd.
Address
No. 12-10-167, Bharat Nagar
City
Hyderabad - 500018
State
Telangana
Tel. No.
040-23818475, 23818476, 23868023
Fax No.
040-23868024
MANAGEMENT
Name
Designation
V C Nannapaneni
Chairman & Managing Director
Rajeev Nannapaneni
Vice Chairman & CEO
P Bhaskara Narayana
Director & CFO
A K S Bhujanga Rao
President & Director
T V Rao
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

DCB Bank Recommended on Aug 19th 2014

Recommended price 81.00  |  Peak from reco 117.40 36.36%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Natco Pharma

Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 4,650.04 crore.The company has reported a consolidated sales of Rs 209.06 crore and a Net Profit of Rs 31.24 crore for the quarter ended Sep 2014.

The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, T V Rao - Director, G S Murthy - Director, B S Bajaj - Director, D G Prasad - Director, Vivek Chhachhi - Director, Tarun Khanna - Alternate Director, Leela Digumarti - Additional Director, P S R K Prasad - Additional Director.

It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.

Its Registered office is at Natco House, Road No.2,,Banjara Hills Hyderabad,Telangana - 500033.

Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.

Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Natco Pharma